Innovacell Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

48

Website

www.innovacell.co.jp

Country

Japan

Exchange

Tokyo

Innovacell develops, manufactures, and sells cell therapy and regenerative medicine products. The company's products include ICEF15, a cell treatment for urgent fecal incontinence.

Its portfolio also includes ICEF16, a cell therapy for leaky fecal incontinence, and ICES13, a cell therapy for stress urinary incontinence. Innovacell Inc. was incorporated in 2021 and is based in Shinagawa, Japan.

Key Stats

52-Week Range

¥377.00¥1248.00

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-89.02

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.